Swedish Orphan Biovitrum recently reported Phase 3 data showing that Tryngolza (olezarsen) and pozdeutinurad both met key efficacy and safety goals in severe hypertriglyceridemia and gout, ...

This readout could boost Tryngolza’s standing in its potential rivalry with Arrowhead’s Redemplo in severe ...

Detailed price information for Swedish Orphan Biovit Ord (BIOVF) from The Globe and Mail including charting and trades.

Sobi® (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza® (olezarsen) reduced the relative risk of acute pancreatitis events by 85% ...

Sobi (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza (olezarsen) reduced the relative ...

Detailed price information for Amarin Corp ADR (AMRN-Q) from The Globe and Mail including charting and trades.

13:43, Wed, Jun 3, 2026 Updated: 13:44, Wed, Jun 3, 2026 A green fruit commonly featured in soups might be a hidden ally in the fight against high cholesterol, a pharmacist has revealed. Cholesterol ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the completion ...

Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more therapies or technologies that, if effective, could improve treatments ...

Acute pancreatitis is a common and costly gastrointestinal condition with significant risk of complications. The 2024 ...